首页 › 基金 › Davern Capital Partners, LP › GENB

Davern Capital Partners, LP 对 GENB 的持仓历史

Generate Biomedicines Inc · 医疗保健

Davern Capital Partners, LP 在 Q3 2026 的 13F 申报中披露持有 GENB(Generate Biomedicines Inc)824,679 股,市值约 US$12.4M,约占其申报组合的 2.41%,在其申报持仓中市值排名第 15 位。 Davern Capital Partners, LP 最近 3 个申报季度中有 3 个季度披露了 GENB 持仓,最早可追溯至 Q1 2026。

最新持仓 (Q3 2026)824.68K 股
申报持仓市值$12.39M
组合权重2.41%
首次申报Q1 2026
最近变动持有
更新于2026-11-12

最后更新: 2026-11-12 · 来源: SEC EDGAR Form 13F-HR

Davern Capital Partners, LP 对 GENB 的持仓演变

Davern Capital Partners, LP 于 Q1 2026 首次披露 GENB 持仓:591,800 股(约 US$7.4M)。 该持仓在 Q2 2026 达到峰值 824,679 股,市值约 US$13.9M。 在 3 次申报中,Davern Capital Partners, LP 1 次增持、0 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 824,679 股、市值约 US$12.4M。 持仓曾出现大幅变动:Q2 2026 增持约 39% (随后一个季度股价下跌 11%)。

逐季持仓明细

季度股数金额变化
Q1 2026 591.80K $7.40M 新进
Q2 2026 824.68K $13.91M 增持
Q3 2026 824.68K $12.39M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 GENB 与 13F 数据

GENB(Generate Biomedicines Inc)属于医疗保健行业。我们追踪的基金中还有 96 只申报持有 GENB,申报仓位最大的包括:Flagship Pioneering, LLC (US$1.06B), BRAIDWELL LP (US$55.4M), ARCH Venture Management, LLC (US$32.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 GENB 的基金

查看 GENB 的全部基金持有人 →

常见问题

How long has Davern Capital Partners, LP held GENB?

Davern Capital Partners, LP has disclosed GENB holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Davern Capital Partners, LP's current position in GENB?

As of Q3 2026, Davern Capital Partners, LP holds 824.68K shares of GENB (Generate Biomedicines Inc), valued at $12.39M, representing 2.41% of its reported portfolio and ranking #15.

Has Davern Capital Partners, LP been buying or selling GENB?

In the latest 13F filing (Q3 2026), Davern Capital Partners, LP held unchanged its position in GENB. The position peaked in Q2 2026 at 824.68K shares.

Which other funds hold GENB?

Other major institutional holders of GENB include Flagship Pioneering, LLC, BRAIDWELL LP, ARCH Venture Management, LLC, among 96 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.